Abstract:Glioblastoma (GBM) is the most common and lethal brain tumor in adults. Ionizing radiation (IR) is a standard treatment for GBM patients and results in DNA damage. However, the clinical efficacy of IR is limited due to therapeutic resistance. The programmed death ligand 1 (PD-L1) blockade has a shown the potential to increase the efficacy of radiotherapy by inhibiting DNA damage and repair responses. The miR-33a-5p is an essential microRNA that promotes GBM growth and self-renewal. In this study, we investigated whether a PD-L1 inhibitor (a small molecule inhibitor) exerted radio-sensitive effects to impart an anti-tumor function in GBM cells by modulating miR-33a-5p. U87 MG cells and U251 cells were pretreated with PD-L1 inhibitor. The PD-L1 inhibitor-induced radio-sensitivity in these cells was assessed by assaying cellular apoptosis, clonogenic survival assays, and migration. TargetScan and luciferase assay showed that miR-33a-5p targeted the phosphatase and tensin homolog (PTEN) 3′ untranslated region. The expression level of PTEN was measured by western blotting, and was also silenced using small interfering RNAs. The levels of DNA damage following radiation was measured by the presence of γ-H2AX foci, cell cycle, and the mRNA of the DNA damage-related genes, BRCA1, NBS1, RAD50, and MRE11. Our results demonstrated that the PD-L1 inhibitor significantly decreased the expression of the target gene, miR-33a-5p. In addition, pretreatment of U87 MG and U251 cells with the PD-L1 inhibitor increased radio-sensitivity, as indicated by increased apoptosis, while decreased survival and migration of GBM cells. Mir-33a-5p overexpression or silencing PTEN in U87 MG and U251 cells significantly attenuated PD-L1 radiosensitive effect. Additionally, PD-L1 inhibitor treatment suppressed the expression of the DNA damage response-related genes, BRCA1, NBS1, RAD50, and MRE11. Our results demonstrated a novel role for the PD-L1 inhibitor in inducing radio- sensitivity in GBM cells, where inhibiting miR-33a-5p, leading to PTEN activated, and inducing DNA damage was crucial for antitumor immunotherapies to treat GBM.

MiR-26a Enhances the Radiosensitivity of Glioblastoma Multiforme Cells Through Targeting of Ataxia-Telangiectasia Mutated.

miR-20a mediates temozolomide-resistance in glioblastoma cells via negatively regulating LRIG1 expression.

MicroRNA-223 Enhances Radiation Sensitivity of U87MG Cells in Vitro and in Vivo by Targeting Ataxia Telangiectasia Mutated.

Pancreatic Cancer Cells Hijack Tumor Suppressive Microrna-26A to Promote Radioresistance and Potentiate Tumor Repopulation

Upregulation of Mir-96 Promotes Radioresistance in Glioblastoma Cells Via Targeting PDCD4

LncRNA RBPMS-AS1 Promotes NRGN Transcription to Enhance the Radiosensitivity of Glioblastoma Through the Microrna-301A-3p/camta1 Axis

Silencing of ataxia-telangiectasia mutated by siRNA enhances the in vitro and in vivo radiosensitivity of glioma.

MicroRNA-26a promotes tumor growth and angiogenesis in glioma by directly targeting prohibitin.

Inhibition of Mir-630 Enhances the Cell Resistance to Radiation by Directly Targeting CDC14A in Human Glioma.

MiR-26a enhances invasive capacity by suppressing GSK3β in human lung cancer cells

Knockdown of ATRX enhances radiosensitivity in glioblastoma

Silencing of ATM Expression by Sirna Technique Contributes to Glioma Stem Cell Radiosensitivity in Vitro and in Vivo.

Mir-146B-5p Suppresses Glioblastoma Cell Resistance to Temozolomide Through Targeting TRAF6

Differential expression of microRNAs in postoperative radiotherapy sensitive and resistant patients with glioblastoma multiforme

Mir-1258 Attenuates Tumorigenesis Through Targeting E2F1 to Inhibit PCNA and MMP2 Transcription in Glioblastoma.

Mir-30A Radiosensitizes Non-Small Cell Lung Cancer by Targeting ATF1 That is Involved in the Phosphorylation of ATM.

MicroRNA-17-5p and MicroRNA-130b-3p Promote Radioresistance of Glioma Stem Cells by Targeting PTEN/AKT/HIF-1α Pathway-Controlled Phosphopentose Metabolism

PD-L1 Inhibitor Regulates the miR-33a-5p/PTEN Signaling Pathway and Can Be Targeted to Sensitize Glioblastomas to Radiation

MicroRNA-26a Acts As a Tumor Suppressor Inhibiting Gallbladder Cancer Cell Proliferation by Directly Targeting HMGA2.

Mir-144-5p Enhances The Radiosensitivity Of Non-Small-Cell Lung Cancer Cells Via Targeting Atf2

C-Myc Negatively Controls the Tumor Suppressor PTEN by Upregulating Mir-26A in Glioblastoma Multiforme Cells